PURPOSE: To determine whether brain and plasma equilibrium of a proposed PET tracer for 5-HT(1A), [(18)F]FPWAY, can be achieved in a sufficiently short time for practical use of the brain to plasma equilibrium distribution ratio (DR) to monitor receptor availability with and without isoflurane anesthesia. METHODS: Awake (n=4) and isoflurane-anesthetized (n=4) rats were administered a continuous 60 min intravenous infusion of [(18)F]FPWAY with timed arterial blood sampling. Brains of the isoflurane-anesthetized rats were scanned with the ATLAS small animal PET scanner; awake rats were not. All rats were killed at 60 min and scanned postmortem for 15 min, followed by brain slicing for autoradiography. Several regions of interest (ROIs) were defined in the PET images as well as in the autoradiographic images. Regional DRs were calculated as total activity in the brain ROI divided by plasma [(18)F]FPWAY activity. RESULTS: DRs in the anesthetized animals were constant between 30 and 60 min, indicating that near equilibrium between brain and plasma had been achieved by approximately 30 min. DRs determined from postmortem PET data were higher in the isoflurane-anesthetized rats by 24% (not significant) and 33% (p=0.065) in whole brain and hippocampus, respectively. DRs determined from autoradiographic data were greater in isoflurane-anesthetized rats in medial hippocampus, lateral hippocampus, and cerebellum by 33% (p=0.054), 63% (p<0.01), and 32% (p<0.05), respectively. CONCLUSION: [(18)F]FPWAY could be an appropriate ligand for monitoring changes in receptor availability in the serotonergic system using a bolus/infusion paradigm. One possible explanation for higher DRs in anesthetized rats may be a reduction in endogenous 5-HT secretion under isoflurane anesthesia.
PURPOSE: To determine whether brain and plasma equilibrium of a proposed PET tracer for 5-HT(1A), [(18)F]FPWAY, can be achieved in a sufficiently short time for practical use of the brain to plasma equilibrium distribution ratio (DR) to monitor receptor availability with and without isoflurane anesthesia. METHODS: Awake (n=4) and isoflurane-anesthetized (n=4) rats were administered a continuous 60 min intravenous infusion of [(18)F]FPWAY with timed arterial blood sampling. Brains of the isoflurane-anesthetized rats were scanned with the ATLAS small animal PET scanner; awake rats were not. All rats were killed at 60 min and scanned postmortem for 15 min, followed by brain slicing for autoradiography. Several regions of interest (ROIs) were defined in the PET images as well as in the autoradiographic images. Regional DRs were calculated as total activity in the brain ROI divided by plasma [(18)F]FPWAY activity. RESULTS: DRs in the anesthetized animals were constant between 30 and 60 min, indicating that near equilibrium between brain and plasma had been achieved by approximately 30 min. DRs determined from postmortem PET data were higher in the isoflurane-anesthetized rats by 24% (not significant) and 33% (p=0.065) in whole brain and hippocampus, respectively. DRs determined from autoradiographic data were greater in isoflurane-anesthetized rats in medial hippocampus, lateral hippocampus, and cerebellum by 33% (p=0.054), 63% (p<0.01), and 32% (p<0.05), respectively. CONCLUSION: [(18)F]FPWAY could be an appropriate ligand for monitoring changes in receptor availability in the serotonergic system using a bolus/infusion paradigm. One possible explanation for higher DRs in anesthetized rats may be a reduction in endogenous 5-HT secretion under isoflurane anesthesia.
Authors: L Lang; E Jagoda; B Schmall; B K Vuong; H R Adams; D L Nelson; R E Carson; W C Eckelman Journal: J Med Chem Date: 1999-05-06 Impact factor: 7.446
Authors: Giampiero Giovacchini; Lixin Lang; Ying Ma; Peter Herscovitch; William C Eckelman; Richard E Carson Journal: Neuroimage Date: 2005-07-01 Impact factor: 6.556
Authors: Ying Ma; Lixin Lang; Dale O Kiesewetter; William C Eckelman Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2002-11-15 Impact factor: 3.205
Authors: Dustin W Wooten; Ansel T Hillmer; Jeffrey M Moirano; Elizabeth O Ahlers; Maxim Slesarev; Todd E Barnhart; Jogeshwar Mukherjee; Mary L Schneider; Bradley T Christian Journal: J Cereb Blood Flow Metab Date: 2012-04-04 Impact factor: 6.200
Authors: Christina S Hines; Masahiro Fujita; Sami S Zoghbi; Jin Su Kim; Zenaide Quezado; Peter Herscovitch; Ning Miao; Maria D Ferraris Araneta; Cheryl Morse; Victor W Pike; Julia Labovsky; Robert B Innis Journal: J Nucl Med Date: 2012-11-12 Impact factor: 10.057
Authors: Gregory M Sullivan; Ramin V Parsey; J S Dileep Kumar; Victoria Arango; Suham A Kassir; Yung-Yu Huang; Norman R Simpson; Ronald L Van Heertum; J John Mann Journal: Nucl Med Biol Date: 2007-03-30 Impact factor: 2.408
Authors: Tetsuji Itoh; Kohji Abe; Sami S Zoghbi; Osamu Inoue; Jinsoo Hong; Masao Imaizumi; Victor W Pike; Robert B Innis; Masahiro Fujita Journal: J Nucl Med Date: 2009-04-16 Impact factor: 10.057